David Windley
Stock Analyst at Jefferies
(3.68)
# 712
Out of 4,784 analysts
187
Total ratings
66.97%
Success rate
14.16%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Downgrades: Underperform | $68 → $52 | $60.04 | -13.39% | 26 | Dec 10, 2024 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $13.30 | -9.77% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $264.58 | -4.38% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $8.03 | +161.52% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $312.36 | +10.45% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $325.04 | +29.83% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $322.85 | -8.01% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $177.39 | +36.42% | 4 | Jul 24, 2024 | |
| UNH UnitedHealth Group | Upgrades: Buy | $481 → $647 | $516.04 | +25.38% | 26 | Jul 17, 2024 | |
| NOTV Inotiv | Downgrades: Hold | $12 → $3.75 | $2.15 | +74.42% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $432.00 | +39.81% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $491.84 | -23.76% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $11.77 | +31.69% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $234.21 | +15.28% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $9.91 | +56.41% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $222.20 | +141.22% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $20.29 | +42.93% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $155.55 | +30.50% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $179.07 | +68.65% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $8.09 | +2,965.51% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.41 | - | 5 | Oct 9, 2017 |
Centene
Dec 10, 2024
Downgrades: Underperform
Price Target: $68 → $52
Current: $60.04
Upside: -13.39%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $13.30
Upside: -9.77%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $264.58
Upside: -4.38%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $8.03
Upside: +161.52%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $312.36
Upside: +10.45%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $325.04
Upside: +29.83%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $322.85
Upside: -8.01%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $177.39
Upside: +36.42%
UnitedHealth Group
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $516.04
Upside: +25.38%
Inotiv
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $2.15
Upside: +74.42%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $432.00
Upside: +39.81%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $491.84
Upside: -23.76%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $11.77
Upside: +31.69%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $234.21
Upside: +15.28%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $9.91
Upside: +56.41%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $222.20
Upside: +141.22%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $20.29
Upside: +42.93%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $155.55
Upside: +30.50%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $179.07
Upside: +68.65%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $8.09
Upside: +2,965.51%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.41
Upside: -